Epithelial-stromal Interaction Increases Cell Proliferation, Survival and Tumorigenicity in a Mouse Model of Human Epithelial Ovarian Cancer

Cancer Statistics, 2006

Jemal, A., Siegel, R. L., Ward, E. M., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,309 · see citing works

Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis

Hicklin, D. J., & Ellis, L. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.081 · Cited by 3,010 · see citing works

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,693 · see citing works

Isolation of a tumor factor responsible for angiogenesis

Folkman, J., Merler, E., Abernathy, C., & Williams, G. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.133.2.275 · Cited by 1,663 · see citing works

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320 · see citing works

Ovarian cancer: epidemiology, biology, and prognostic factors.

Holschneider, C., & Berek, J. (2000) · Seminars in surgical oncology · doi:10.1002/1098-2388(200007/08)19:1 · Cited by 764 · see citing works

Development of a Syngeneic Mouse Model for Events Related to Ovarian Cancer

Roby, K. F., Taylor, C. C., Sweetwood, J. P., Cheng, Y., Pace, J. L., Tawfik, O., Persons, D. L., Smith, P. G., & Terranova, P. F. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.585 · Cited by 593 · see citing works

Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.

Connolly, D. C., Bao, R., Nikitin, A. Y., Stephens, K. C., Poole, T. W., Xiang, H., Harris, S. S., Vanderhyden, B. C., & Hamilton, T. C. (2003) · PubMed · Cited by 311 · see citing works

Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer

Shaw, T. J., Senterman, M. K., Dawson, K. M., Crane, C. A., & Vanderhyden, B. C. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.08.013 · Cited by 278 · see citing works

Pathology of ovarian cancer precursors

Scully, R. E. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590928 · Cited by 268 · see citing works

Markedly Elevated Levels of Vascular Endothelial Growth Factor in Malignant Ascites

Zebrowski, B. K., Liu, W., Ramirez, K., Akagi, Y., Mills, G. B., & Ellis, L. M. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0373-0 · Cited by 254 · see citing works

Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium

Ahmed, N., Maines‐Bandiera, S., Quinn, M. A., Unger, W. G., Dedhar, S., & Auersperg, N. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00478.2005 · Cited by 206 · see citing works

Differential Expression of the Angiogenic Factor Genes Vascular Endothelial Growth Factor (VEGF) and Endocrine Gland-Derived VEGF in Normal and Polycystic Human Ovaries

Ferrara, N., Frantz, G. D., LeCouter, J. E., Dillard‐Telm, L., Pham, T., Draksharapu, A., Giordano, T. J., & Peale, F. V., Jr. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64322-2 · Cited by 198 · see citing works

Immune Enhancement of Skin Carcinogenesis by CD4+ T Cells

Daniel, D., Meyer-Morse, N., Bergsland, E. K., Dehne, K., Coussens, L. M., & Hanahan, D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021047 · Cited by 180 · see citing works

Patterns and Progress in Ovarian Cancer Over 14 Years

Chan, J. K., Cheung, M. K., Husain, A., Teng, N. N. H., West, D. W., Whittemore, A. S., Berek, J. S., & Osann, K. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000231680.58221.a7 · Cited by 163 · see citing works

Generation of a Syngeneic Mouse Model to Study the Effects of Vascular Endothelial Growth Factor in Ovarian Carcinoma

Zhang, L., Yang, N., Conejo Garcia, J.-R., Mohamed, A., Benencia, F., Rubin, S. C., Allman, D., & Coukos, G. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64505-1 · Cited by 151 · see citing works

Vascular Endothelial Growth Factor and Its Receptor, Flk-1/KDR, Are Cytoprotective in the Extravascular Compartment of the Ovarian Follicle

Greenaway, J. B., Connor, K. L., Pedersen, H. G., Coomber, B. L., LaMarre, J., & Petrik, J. (2004) · Endocrinology · doi:10.1210/en.2003-1620 · Cited by 145 · see citing works

Peritoneal implants from ovarian tumors: CT findings.

Buy, J., Moss, A., Ghossain, M. A., Sciot, C., Malbec, L., Vadrot, D., Paniel, B., & Decroix, Y. (1988) · Radiology · doi:10.1148/radiology.169.3.3186993 · Cited by 116 · see citing works

Influence of in vivo growth on human glioma cell line gene expression: Convergent profiles under orthotopic conditions

Camphausen, K. A., Purow, B. W., Sproull, M. T., Scott, T., Ozawa, T., Deen, D. F., & Tofilon, P. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502887102 · Cited by 109 · see citing works

Roles of KLF6 and KLF6-SV1 in Ovarian Cancer Progression and Intraperitoneal Dissemination

DiFeo, A. V., Narla, G., Hirshfeld, J., Camacho‐Vanegas, O., Narla, J., Rose, S. L., Kalir, T., Yao, S., Levine, A. C., Birrer, M. J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0054 · Cited by 107 · see citing works

Human ovarian surface epithelium in primary culture

Auersperg, N., Siemens, C. H., & Myrdal, S. E. (1984) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02618290 · Cited by 99 · see citing works

Sequential Molecular and Cellular Events during Neoplastic Progression: A Mouse Syngeneic Ovarian Cancer Model

Roberts, P. C., Mottillo, E. P., Baxa, A. C., Heng, H. H., Doyon‐Reale, N., Grégoire, L., Lancaster, W. D., Rabah, R. M., & Schmelz, E. M. (2005) · Neoplasia · doi:10.1593/neo.05358 · Cited by 97 · see citing works

Screening for ovarian cancer.

Jacobs, I. J., & Oram, D. (1988) · PubMed · Cited by 81 · see citing works

Screening for Ovarian Cancer

Rosenthal, A. N., Menon, U., & Jacobs, I. J. (2006) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-200609000-00004 · Cited by 81 · see citing works

Pathophysiological Dynamics of Human Ovarian Surface Epithelial Cells in Epithelial Ovarian Carcinogenesis

Okamura, H., & Katabuchi, H. (2004) · International review of cytology · doi:10.1016/s0074-7696(04)42001-4 · Cited by 80 · see citing works

Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up

Rudlowski, C., PICKART, A.-K., Fuhljahn, C., Friepoertner, T., Schlehe, B., Biesterfeld, S., & Schroeder, W. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00307.x · Cited by 80 · see citing works

Ascites induces modulation of α6β1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma

Ahmed, N., Riley, C. B., Oliva, K., Rice, G. E., & Quinn, M. A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602495 · Cited by 63 · see citing works

Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts

Kaminski, A., Hahne, J. C., Haddouti, E.-M., Florin, A., Wellmann, A., & Wernert, N. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.5.941 · Cited by 63 · see citing works

Analysis of Tumor-Host Interactions by Gene Expression Profiling of Lung Adenocarcinoma Xenografts Identifies Genes Involved in Tumor Formation

Creighton, C. J., Bromberg-White, J. L., Misek, D. E., Monsma, D. J., Brichory, F., Kuick, R. D., Giordano, T. J., Gao, W., Omenn, G. S., Webb, C. P., et al. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0189 · Cited by 62 · see citing works

Phosphatidylinostol 3-Kinase Mediates Angiogenesis and Vascular Permeability Associated with Ovarian Carcinoma

Hu, L., Hofmann, J., & Jaffe, R. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0206 · Cited by 55 · see citing works

Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors.

Inan, S., Vatansever, S., Çelik-Özenci, Ç., Sanci, M., Dicle, N., & Demir, R. (2006) · PubMed · doi:10.14670/hh-21.1055 · Cited by 45 · see citing works

Brain metastases of epithelial ovarian carcinoma responding to cisplatin and gemcitabine combination chemotherapy: a case report and review of the literature

Melichar, B., Urminská, H., Kohlová, T., Nová, M., & Česák, T. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.05.026 · Cited by 36 · see citing works

Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy

Manenti, L., Riccardi, E., Marchini, S., Naumova, E., Floriani, I., Garofalo, A., Dossi, R., Marrazzo, E., Ribatti, D., Scanziani, E., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0305 · Cited by 30 · see citing works

Recombinant Adeno-Associated Virus 2-Mediated Antiangiogenic Prevention in a Mouse Model of Intraperitoneal Ovarian Cancer

Isayeva, T., Ren, C., & Ponnazhagan, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1342.11.3 · Cited by 28 · see citing works

Metastasis to sigmoid colon mucosa and submucosa from serous borderline ovarian tumor: response to hormone therapy

LEE, E.-J., Deavers, M. T., Hughes, J. I., Lee, J. H., & Kavanagh, J. J. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00206.x · Cited by 26 · see citing works

Pulmonary fibroblasts stimulate the proliferation of cell lines from human lung adenocarcinomas

Cekanova, M., Masi, T. J., Plummer, H. K., Majidi, M., Fedoročko, P., & Schuller, H. M. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000217434.48870.f9 · Cited by 22 · see citing works

Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nonmalignant ascites

Nascimento, I., Schaer, R., Lemaire, D. C., FREIRE, S., Paule, B. J. A., CARVALHO, S., Meyer, R., & Schaer-Barbosa, H. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm1120904.x · Cited by 16 · see citing works

Paracrine VEGF/VE-Cadherin Action on Ovarian Cancer Permeability

Hu, L., Ferrara, N., & Jaffe, R. B. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623101010 · Cited by 13 · see citing works

Immunohistochemical profile of ovarian inclusion cysts in patients with and without ovarian carcinoma

Mittal, K., Goswami, S., & Demopoulos, R. I. (1995) · The Histochemical Journal · doi:10.1007/bf00243906 · Cited by 7 · see citing works

Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth

Ghosh, S., & Maity, P. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.05.005 · Cited by 6 · see citing works

Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion

Zhang, Y., Tang, H., Cai, J., Zhang, T., Guo, J., Feng, D., & Wang, Z. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.011 · Cited by 244 · see citing works

FABP4 as a key determinant of metastatic potential of ovarian cancer

Gharpure, K. M., Pradeep, S., Sans, M., Rupaimoole, R., Ivan, C., Wu, S. Y., Bayraktar, E., Nagaraja, A. S., Mangala, L. S., Zhang, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04987-y · Cited by 210 · see citing works

Epithelial ovarian cancer experimental models

Lengyel, E. R., Burdette, J. E., Kenny, H. A., Matei, D. E., Pilrose, J. M., Haluska, P., Nephew, K. P., Hales, D. B., & Stack, M. S. (2013) · Oncogene · doi:10.1038/onc.2013.321 · Cited by 209 · see citing works

Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer

Schauer, I. G., Sood, A. K., Mok, S. C., & Liu, J. (2011) · Neoplasia · doi:10.1593/neo.101720 · Cited by 155 · see citing works

Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor

Gartung, A., Yang, J., Sukhatme, V. P., Bielenberg, D. R., Fernandes, D., Chang, J., Schmidt, B. A. R., Hwang, S. H., Zurakowski, D., Huang, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803999116 · Cited by 121 · see citing works

Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression

Ward, K. K., Tancioni, I., Lawson, C., Miller, N. L. G., Jean, C., Chen, X. L., Uryu, S. A., Kim, J., Tarin, D., Stupack, D. G., et al. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9562-5 · Cited by 109 · see citing works

Ovarian Cancer Cell Detachment and Multicellular Aggregate Formation Are Regulated by Membrane Type 1 Matrix Metalloproteinase: A Potential Role in I.p. Metastatic Dissemination

Moss, N. M., Barbolina, M. V., Liu, Y., Sun, L., Munshi, H. G., & Stack, M. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4151 · Cited by 105 · see citing works

Extracellular Matrix Proteins and Tumor Angiogenesis

Campbell, N., Kellenberger, L. D., Greenaway, J. B., Moorehead, R. A., Linnerth-Petrik, N. M., & Petrik, J. (2010) · Journal of Oncology · doi:10.1155/2010/586905 · Cited by 101 · see citing works

Comparative Biodistribution of PAMAM Dendrimers and HPMA Copolymers in Ovarian-Tumor-Bearing Mice

Sadekar, S., Ray, A., Janat-Amsbury, M. M., Peterson, C. M., & Ghandehari, H. (2010) · Biomacromolecules · doi:10.1021/bm101046d · Cited by 96 · see citing works

Cowpea Mosaic Virus Promotes Anti‐Tumor Activity and Immune Memory in a Mouse Ovarian Tumor Model

Wang, C., Fiering, S., & Steinmetz, N. F. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900003 · Cited by 88 · see citing works

The metabolic cross‐talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role

Thuwajit, C., Ferraresi, A., Titone, R., Thuwajit, P., & Isidoro, C. (2017) · Medicinal Research Reviews · doi:10.1002/med.21473 · Cited by 84 · see citing works

Biocompatible mannosylated endosomal-escape nanoparticles enhance selective delivery of short nucleotide sequences to tumor associated macrophages

Ortega, R. A., Barham, W. J., Kumar, B., Tikhomirov, O., McFadden, I., Yull, F. E., & Giorgio, T. D. (2014) · Nanoscale · doi:10.1039/c4nr03962a · Cited by 77 · see citing works

The Thrombospondin-1 Mimetic ABT-510 Increases the Uptake and Effectiveness of Cisplatin and Paclitaxel in a Mouse Model of Epithelial Ovarian Cancer

Campbell, N., Greenaway, J. B., Henkin, J., Moorehead, R. A., & Petrik, J. (2010) · Neoplasia · doi:10.1593/neo.91880 · Cited by 76 · see citing works

The exosomal integrin α5β1/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration

Li, X., Tang, M., Zhu, Q., Wang, X., Lin, Y., & Wang, X. (2020) · Cellular Oncology · doi:10.1007/s13402-019-00486-4 · Cited by 75 · see citing works

Opposing Functions of Akt Isoforms in Lung Tumor Initiation and Progression

Linnerth-Petrik, N. M., Santry, L. A., Petrik, J., & Wootton, S. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094595 · Cited by 71 · see citing works

ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer

Greenaway, J. B., Henkin, J., Lawler, J., Moorehead, R. A., & Petrik, J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0864 · Cited by 71 · see citing works

Interferon-ε is a tumour suppressor and restricts ovarian cancer

Marks, Z. R. C., Campbell, N. K., Mangan, N. E., Vandenberg, C. J., Gearing, L. J., Matthews, A. Y., Gould, J. A., Tate, M. D., Wray‐McCann, G., Ying, L., et al. (2023) · Nature · doi:10.1038/s41586-023-06421-w · Cited by 70 · see citing works

Combined therapy with thrombospondin‐1 type I repeats (3TSR) and chemotherapy induces regression and significandy improves survival in a preclinical model of advanced stage epithelial ovarian cancer

Russell, S. J., Duquette, M. A., Liu, J. F., Drapkin, R., Lawler, J., & Petrik, J. (2014) · The FASEB Journal · doi:10.1096/fj.14-261636 · Cited by 70 · see citing works

A New Spontaneously Transformed Syngeneic Model of High-Grade Serous Ovarian Cancer with a Tumor-Initiating Cell Population

McCloskey, C. W., Goldberg, R. L., Carter, L. E., Gamwell, L. F., Al-Hujaily, E. M., Collins, O., Macdonald, E. A., Garson, K., Daneshmand, M., Carmona, E., et al. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00053 · Cited by 67 · see citing works

Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine

Yee, C., Dickson, K.-A., Muntasir, M. N., Ma, Y., & Marsh, D. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.836984 · Cited by 66 · see citing works

Preclinical models in radiation oncology

Kahn, J. M., Tofilon, P. J., & Camphausen, K. A. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-223 · Cited by 63 · see citing works

The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer

Kellenberger, L. D., Bruin, J. E., Greenaway, J. B., Campbell, N., Moorehead, R. A., Holloway, A. C., & Petrik, J. (2010) · Journal of Oncology · doi:10.1155/2010/514310 · Cited by 61 · see citing works

Ovarian cancer mouse models: a summary of current models and their limitations

Fong, M., & Kakar, S. S. (2009) · Journal of Ovarian Research · doi:10.1186/1757-2215-2-12 · Cited by 58 · see citing works

Development of a syngeneic mouse model of epithelial ovarian cancer

Quinn, B. A., Fang, X., Bickel, L. E., Martin, L. P., Xiang, H., Klein–Szanto, A. J., & Connolly, D. C. (2010) · Journal of Ovarian Research · doi:10.1186/1757-2215-3-24 · Cited by 55 · see citing works

Microenvironmental Regulation of Ovarian Cancer Metastasis

Barbolina, M. V., Moss, N. M., Westfall, S. D., Liu, Y., Burkhalter, R. J., Marga, F. S., Forgács, G., Hudson, L. G., & Stack, M. S. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-98094-2_15 · Cited by 53 · see citing works

Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer

Greenaway, J. B., Virtanen, C., Osz, K., Révay, T., Hardy, D. B., Shepherd, T. G., DiMattia, G. E., & Petrik, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10121 · Cited by 51 · see citing works

Akt isoform specific effects in ovarian cancer progression

Linnerth-Petrik, N. M., Santry, L. A., Moorehead, R. A., Jücker, M., Wootton, S. K., & Petrik, J. (2016) · Oncotarget · doi:10.18632/oncotarget.11204 · Cited by 50 · see citing works

ABT-898 Induces Tumor Regression and Prolongs Survival in a Mouse Model of Epithelial Ovarian Cancer

Campbell, N., Greenaway, J. B., Henkin, J., & Petrik, J. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0402 · Cited by 44 · see citing works

An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels

Zahedi, P., Stewart, J., Souza, R. D., Piquette‐Miller, M., & Allen, C. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.025 · Cited by 43 · see citing works

cAMP response element–binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation

Linnerth-Petrik, N. M., Greenaway, J. B., Petrik, J., & Moorehead, R. A. (2008) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.01177.x · Cited by 42 · see citing works

Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer

Souza, R. D., Zahedi, P., Moriyama, E. H., Allen, C. J., Wilson, B. C., & Piquette‐Miller, M. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0249 · Cited by 42 · see citing works

Preclinical models of epithelial ovarian cancer: practical considerations and challenges for a meaningful application

Ciucci, A., Buttarelli, M., Fagotti, A., Scambia, G., & Gallo, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04395-y · Cited by 43 · see citing works

Recent Technological Advances in Using Mouse Models to Study Ovarian Cancer

House, C. D., Hernandez, L. F., & Annunziata, C. M. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00026 · Cited by 39 · see citing works

In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer

Cordero, A. B., Kwon, Y., Xiang, H., & Godwin, A. K. (2010) · Journal of Visualized Experiments · doi:10.3791/2125 · Cited by 39 · see citing works

Fibrillar Type I Collagen Matrices Enhance Metastasis/Invasion of Ovarian Epithelial Cancer Via β1 Integrin and PTEN Signals

Shen, Y., Shen, R., Ge, L., Zhu, Q., & Li, F. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e318263ef34 · Cited by 38 · see citing works

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study

Tang, L., Mei, L.-J., Yang, X., Huang, C., Zhou, Y., Yonemura, Y., & Li, Y. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-53 · Cited by 35 · see citing works

Enhanced anti-tumor efficacy and safety with metronomic intraperitoneal chemotherapy for metastatic ovarian cancer using biodegradable nanotextile implants

Padmakumar, S., Parayath, N. N., Nair, S. V., Menon, D., & Amiji, M. M. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.022 · Cited by 33 · see citing works

Formulation and evaluation of oral microparticulate ovarian cancer vaccines

Tawde, S. A., Chablani, L., Akalkotkar, A., D’Souza, C., Chiriva‐Internati, M., Selvaraj, P., & D’Souza, M. J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.073 · Cited by 30 · see citing works

Animal Models of Ovarian Cancer

Connolly, D. C. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-98094-2_17 · Cited by 30 · see citing works

A novel p70 S6 kinase-microRNA biogenesis axis mediates multicellular spheroid formation in ovarian cancer progression

Lam, S., Ip, C. K. M., Mak, A. S. C., & Wong, A. S. T. (2016) · Oncotarget · doi:10.18632/oncotarget.9345 · Cited by 29 · see citing works

Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model

Lin, K., Sun, S.-P., Wu, J.-I., & Wang, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178937 · Cited by 27 · see citing works

Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion

Carmi, Y. K., Mahmoud, H., Khamaisi, H., Adawi, R., Gopas, J., & Mahajna, J. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186533 · Cited by 26 · see citing works

Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model

Mony, J. T., Zhang, L., Ma, T., Grabosch, S., Tirodkar, T. S., Brozick, J., Tseng, G. C., Elishaev, E., Edwards, R. P., Huang, X., et al. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1712-6 · Cited by 22 · see citing works

Experimental models for ovarian cancer research

Tsang, S. I., Hassan, A. A., To, S. K. Y., & Wong, A. S. T. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113150 · Cited by 22 · see citing works

Characterization and evaluation of pre-clinical suitability of a syngeneic orthotopic mouse ovarian cancer model.

Cho, S., Sun, Y., Soisson, A. P., Dodson, M. K., Peterson, C. M., Jarboe, E. A., Kennedy, A., & Janat-Amsbury, M. M. (2013) · PubMed · Cited by 22 · see citing works

Notch3 signaling promotes tumor cell adhesion and progression in a murine epithelial ovarian cancer model

Price, J. C., Azizi, E., Naiche, L. A., Parvani, J. G., Shukla, P., Kim, S., Slack‐Davis, J. K., Pe’er, D., & Kitajewski, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233962 · Cited by 21 · see citing works

Generation of a syngeneic mouse model to study the intraperitoneal dissemination of ovarian cancer with in vivo luciferase imaging

Toyoshima, M., Tanaka, Y., Matumoto, M., Yamazaki, M., Nagase, S., Sugamura, K., & Yaegashi, N. (2009) · Luminescence · doi:10.1002/bio.1112 · Cited by 21 · see citing works

CD90low MSCs modulate intratumoral immunity to confer antitumor activity in a mouse model of ovarian cancer

Zeng, Y. C., Li, B., Li, T., Liu, W., Ran, C., Penson, R. T., Poznansky, M. C., Du, Y., & Chen, H. (2019) · Oncotarget · doi:10.18632/oncotarget.27065 · Cited by 18 · see citing works

Hyperglycemia promotes insulin-independent ovarian tumor growth

Kellenberger, L. D., & Petrik, J. (2018) · Gynecologic Oncology · doi:10.1016/j.ygyno.2018.02.003 · Cited by 17 · see citing works

Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions

Jurisicova, A., Jurišica, I., & Kislinger, T. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.4.551 · Cited by 17 · see citing works

Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexia

Delfinis, L. J., Ogilvie, L. M., Khajehzadehshoushtar, S., Gandhi, S., Garibotti, M. C., Thuhan, A. K., Matuszewska, K., Pereira, M., Jones, R. G., Cheng, A. J., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101976 · Cited by 15 · see citing works

The effect of talc particles on phagocytes in co-culture with ovarian cancer cells

Mandarino, A., Gregory, D. J., McGuire, C. C., LeBlanc, B. W., Witt, H. A., Rivera, L. M., Godleski, J. J., & Fedulov, A. V. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108676 · Cited by 15 · see citing works

Cardiac Atrophy, Dysfunction, and Metabolic Impairments

Ogilvie, L. M., Delfinis, L. J., Coyle‐Asbil, B., Vudatha, V., Alshamali, R., Garlisi, B., Pereira, M., Matuszewska, K., Garibotti, M. C., Gandhi, S., et al. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.06.008 · Cited by 14 · see citing works

Development of a M cell‐targeted microparticulate platform, BSK02™, for oral immunization against the ovarian cancer antigen, sperm protein 17

Mattila, J., Mirandola, L., & Chiriva‐Internati, M. (2018) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34092 · Cited by 14 · see citing works

An Immunocompetent, Orthotopic Mouse Model of Epithelial Ovarian Cancer Utilizing Tissue Engineered Tumor Cell Sheets

Arauchi, A., Yang, C.-H., Cho, S., Jarboe, E. A., Peterson, C. M., Bae, Y. H., Okano, T., & Janat-Amsbury, M. M. (2014) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2014.0040 · Cited by 13 · see citing works

AAV-mediated expression of 3TSR inhibits tumor and metastatic lesion development and extends survival in a murine model of epithelial ovarian carcinoma

Yu, D. L., Stegelmeier, A. A., Chow, N., Rghei, A. D., Matuszewska, K., Lawler, J., Bridle, B. W., Petrik, J., & Wootton, S. K. (2019) · Cancer Gene Therapy · doi:10.1038/s41417-019-0108-8 · Cited by 13 · see citing works

An immune competent orthotopic model of endometrial cancer with metastasis

Fedorko, A., Kim, T. H., Broaddus, R. R., Schmandt, R. E., Chandramouli, G. V. R., Kim, H. I., Jeong, J., & Risinger, J. I. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04075 · Cited by 13 · see citing works

Detecting peritoneal dissemination of ovarian cancer in mice by DWIBS

Lee, H., Luci, J. J., Tantawy, M. N., Lee, H., Nam, K. T., Peterson, T. E., & Price, R. R. (2012) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2012.06.016 · Cited by 12 · see citing works

Changes in mRNA/protein expression and signaling pathways in in vivo passaged mouse ovarian cancer cells

Cai, Q., Fan, Q., Buechlein, A. M., Miller, D. F., Nephew, K. P., Liu, S., Wan, J., & Xu, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197404 · Cited by 12 · see citing works

Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model

Lee, Y.-Y., Kollara, A., May, T., & Brown, T. J. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0428-6 · Cited by 12 · see citing works

The Lipidomic Analyses in Low and Highly Aggressive Ovarian Cancer Cell Lines

Zhao, Z., Cai, Q., & Xu, Y. (2015) · Lipids · doi:10.1007/s11745-015-4108-7 · Cited by 11 · see citing works

Influences of Gastrointestinal Microbiota Dysbiosis on Serum Proinflammatory Markers in Epithelial Ovarian Cancer Development and Progression

Mahoney, D. E., Chalise, P., Rahman, F. K., & Pierce, J. D. (2022) · Cancers · doi:10.3390/cancers14123022 · Cited by 9 · see citing works

AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma

Stegelmeier, A. A., Santry, L. A., Guilleman, M. M., Matuszewska, K., Minott, J. A., Yates, J. G. E., Stevens, B. A. Y., Thomas, S. P., Vanderkamp, S., Hanada, K., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10020362 · Cited by 8 · see citing works

Development of a clinically relevant ovarian cancer model incorporating surgical cytoreduction to evaluate treatment of micro-metastatic disease

Morse, C. B., Voillet, V., Bates, B. M., Chiu, E. Y., Garcia, N. M., Gottardo, R., Greenberg, P. D., & Anderson, K. G. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.11.009 · Cited by 8 · see citing works

Orthotopic Model of Ovarian Cancer

Decio, A., & Giavazzi, R. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3999-2_13 · Cited by 7 · see citing works

Knockdown of EPSTI1 alleviates lipopolysaccharide-induced inflammatory injury through regulation of NF-κB signaling in a cellular pneumonia model

Kari, A., Zhihua, M., Aili, Z., Adili, A., Hairula, N., & Abuduhaer, A. (2022) · Allergologia et Immunopathologia · doi:10.15586/aei.v50i3.581 · Cited by 7 · see citing works

Potential molecular signatures in epithelial ovarian cancer by genome wide expression profiling

Wong, Y. L., Dali, A. Z. H. M., Rose, I. M., Jamal, R., & Mokhtar, N. M. (2014) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12182 · Cited by 6 · see citing works

Evaluation of an Intraperitoneal Ovarian Cancer Syngeneic Mouse Model Using 18F-FDG MicroPET Imaging

Lee, H., Tantawy, M. N., Nam, K. T., Choi, I., Peterson, T. E., & Price, R. R. (2010) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182021bda · Cited by 5 · see citing works

Assessing Histology Structures by Ex Vivo MR Microscopy and Exploring the Link Between MRM-Derived Radiomic Features and Histopathology in Ovarian Cancer

Tardieu, M., Lakhman, Y., Khellaf, L., Cardoso, M., Sgarbura, O. A., Colombo, P., Crispin‐Ortuzar, M., Sala, E., Goze‐Bac, C., & Nougaret, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.771848 · Cited by 5 · see citing works

Tracking profiles of genomic instability in spontaneous transformation and tumorigenesis

Lawrenson, L. (2010) · Human Biology · Cited by 5 · see citing works

Orthotopic, Syngeneic Mouse Model to Study the Effects of Epithelial–Stromal Interaction

Greenaway, J. B., & Petrik, J. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-547-7_31 · Cited by 4 · see citing works

Deep sequencing of small RNA libraries from human prostate epithelial and stromal cells reveal distinct pattern of microRNAs primarily predicted to target growth factors

Singh, S., Zheng, Y., Jagadeeswaran, G., Ebron, J. S., Sikand, K., Gupta, S., Sunker, R., & Shukla, G. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.10.038 · Cited by 4 · see citing works

Antigen presentation potential is variable among human ovarian tumour and syngeneic murine models and dictates pre-clinical outcomes of immunotherapy

Alim, L., Adityan, S., Chen, R., Neilson, T., Coleborn, E., Wilkinson, A., He, Y., Irgam, G., Bhavsar, C., Lourie, R., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118141 · Cited by 4 · see citing works

The mitochondrial‐targeted antioxidant SkQ1 prevents skeletal muscle mitochondrial‐apoptotic but not necroptotic signalling during ovarian cancer

Khajehzadehshoushtar, S., Delfinis, L. J., Rahman, F. A., Garibotti, M. C., Gandhi, S., Brahmbhatt, A. N., Morris, B. A., Garlisi, B., Lauks, S., Aitken, C., et al. (2025) · The Journal of Physiology · doi:10.1113/jp287912 · Cited by 3 · see citing works

Overexpression of miR-200s inhibits proliferation and invasion while increasing apoptosis in murine ovarian cancer cells

Carter, R. J., Petrik, J., & Moorehead, R. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0307178 · Cited by 3 · see citing works

Immunocompetent Mouse Model of Ovarian Cancer for In Vivo Imaging

Nuñez-Cruz, S., & Scholler, N. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-547-7_32 · Cited by 3 · see citing works

Assessing Preclinical Research Models for Immunotherapy for Gynecologic Malignancies

Dholakia, J., Scalise, C. B., & Arend, R. C. (2021) · Cancers · doi:10.3390/cancers13071694 · Cited by 3 · see citing works

Multifunctional targeting of docetaxel plus bakuchiol micelles in the treatment of invasion and metastasis of ovarian cancer

Li, Q., Zhu, R.-R., Yu, H.-Y., Liu, C., FeiYan, D., Jiang, Y.-Q., Lin, Y., Li, X., & Wang, W.-J. (2024) · Biomedical Materials · doi:10.1088/1748-605x/ad7556 · Cited by 3 · see citing works

Challenges in Experimental Modeling of Ovarian Cancerogenesis

Petrik, J. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-547-7_28 · Cited by 3 · see citing works

Muscle weakness and mitochondrial stress occur before metastasis in a novel mouse model of ovarian cancer cachexiaPreprint

Delfinis, L. J., Ogilvie, L. M., Khajehzadehshoushtar, S., Gandhi, S., Garibotti, M. C., Thuhan, A. K., Matuszewska, K., Pereira, M., Jones, R. G., Cheng, A. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.08.588639 · Cited by 3 · see citing works

The impact of the ovarian microenvironment on the anti-tumor effect of SPARC on ovarian cancer1This article is part of Special Issue entitled Asilomar Chromatin and has undergone the Journal’s usual peer review process.

Greenaway, J. B., Koehler, A., McCulloch, C. A., Petrik, J., Brown, T. J., & Ringuette, M. J. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-047 · Cited by 2 · see citing works

A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin

Clark, M. B., Kollara, A., Brown, T. J., & May, T. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00895-w · Cited by 2 · see citing works

Photodynamic Treatments for Disseminated Cancer Metastases Using Fiber-Optic Technologies

Kercher, E. M., & Spring, B. Q. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2099-1_14 · Cited by 1 · see citing works

The Impact of VEPH1 on Ovarian Cancer Tumour Progression in a Xenograft Mouse Model

Spybey, T. (2013) · TSpace (University of Toronto) · Cited by 1 · see citing works

Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that precedes ovarian cancer cachexia in micePreprint

Delfinis, L. J., Khajehzadehshoushtar, S., Flewwelling, L. D., Andrews, N. J., Garibotti, M. C., Gandhi, S., Brahmbhatt, A. N., Morris, B. A., Garlisi, B., Lauks, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.22.619751 · Cited by 1 · see citing works

Actividad β-galactosidasa asociada con la senescencia en fibroblastos del estroma ovárico in vitro

Chuaire, L., García-Morcote, C., & Ramírez-Clavijo, S. R. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

Development of pituitary tumor-transforming gene (PTTG) transgenic mice for the treatment of ovarian cancer.

Fong, M. (2012) · doi:10.18297/etd/448

Atividade β-galactosidase associada com a senescência em fibroblastos do estroma ovariano in vitro

Chuaire, L., García-Morcote, C., & Ramírez-Clavijo, S. R. (2011) · Revista Ciencias de la Salud

The effects of hyperglycemia on glucose metabolism in epithelial ovarian cancer

Kellenberger, L. D. (2016) · The Atrium (University of Guelph)

The use of Thrombospondin-1 Mimetic Peptides for the Treatment of Epithelial Ovarian Cancer

Campbell, N. (2012) · The Atrium (University of Guelph)

MOLECULAR DETERMINANTS OF RESIDUAL DISEASE IN OVARIAN CANCER

Gharpure, K. M. (2017) · Digital Commons-TMC (Texas Medical Center)

Assessment Of A Function For Threonyl-Trna Synthetase In Angiogenesis In A Mouse Ovarian Cancer Model

Wo, P. (2017) · ScholarWorks -A service of University of Vermont Libraries (University of Vermont)

PRP4K IS A NOVEL HER2-REGULATED MODIFIER OF ANOIKIS AND TAXANE RESISTANCE

Corkery, D. (2018) · DalSpace (Dalhousie University)

Exploring the Tumor and Premetastatic Microenvironment of the Ovary

McCloskey, C. W. (2019) · uO Research (University of Ottawa) · doi:10.20381/ruor-22876

Lipid Metabolism Reprograming as a Target for Cancer

Xu, Y. (2019) · Oncology Research and Reviews · doi:10.15761/orr.1000128

Estudio de algunos factores relacionados con la senescencia del epitelio superficial del ovario

Chuaire Noack, L. (2020) · doi:10.11144/javeriana.10554.835

The mitochondrial-targeted antioxidant SkQ1 prevents mitochondrial-linked apoptosis but not necroptosis or skeletal muscle atrophy in ovarian cancerPreprint

Khajehzadehshoushtar, S., Delfinis, L. J., Rahman, F. A., Garibotti, M. C., Gandhi, S., Brahmbhatt, A. N., Morris, B. A., Garlisi, B., Lauks, S., Aitken, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.22.617245

A fast-progressing orthotopic ovarian cancer model reveals synergistic antitumor effects of AXL-targeting nanobodies and olaparib

Caro, A. A., Peiró, A. G., Hadadi, É., Berckmans, Y., Elkrim, Y., Debraekeleer, A., Cabrera, G. M., Veirman, K. D., Coosemans, A., & Laoui, D. (2025) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2025.101998

Integrated transcriptomic and proteomic analysis of cancer-suppressive Mesocestoides corti larvae

Vajs, V., Mikeš, L., Leontovyč, R., Tulpová, M., Korená, L., Tolde, O., Macháček, T., Brábek, J., Rösel, D., & Horák, P. (2026) · Parasites & Vectors · doi:10.1186/s13071-026-07391-4

Orthotopic ovarian cancer model using ID8.Vegf/GFP-Luc cells in female C57BL/6 mice

Moreno-Luqui, D., García-Fuentes, R., Juarez-Curiel, E., Salgado-Pascual, A., García-García, M. R., Montes, M., Berraondo, P., & Aranda, F. (2026) · Methods in cell biology · doi:10.1016/bs.mcb.2026.09.002

Orthotopic, Syngeneic Mouse Model to Study the Effects of Epithelial–Stromal Interaction

Greenaway, J. B., & Petrik, J. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-547-7_31 · Cited by 4 · see citing works

Orthotopic Model of Ovarian Cancer

Decio, A., & Giavazzi, R. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3999-2_13 · Cited by 7 · see citing works

Stromal-epithelial interactions in the progression of ovarian cancer: influence and source of tumor stromal cells

Parrott, J. A., Nilsson, E. E., Mosher, R., Magrane, G., Albertson, D. G., Pinkel, D., Gray, J. W., & Skinner, M. K. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00436-1 · Cited by 64 · see citing works

Sheep stromal‐epithelial cell interactions and ovarian tumor progression

Wang‐Johanning, F., Huang, M. L., Liu, J., Rycaj, K., Plummer, J. B., Barnhart, K. F., Satterfield, W. C., & Johanning, G. L. (2007) · International Journal of Cancer · doi:10.1002/ijc.22960 · Cited by 4 · see citing works

Epithelial-Stromal Interactions in Induction of Ovarian Cancer in a Mouse Model

Oršulić, S. (2005) · Defense Technical Information Center (DTIC)